12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Priligy dapoxetine hydrochloride regulatory update

Furiex said the European Commission approved 30 and 60 mg Priligy dapoxetine to treat premature ejaculation (PE) in men ages 18-64. In 2009, an MAA for the product was approved under the EU's decentralized...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >